Publication Date: December 04, 2023Industries:BankruptcyPractice Area:Consumer ProductsCourt: U.S. Court of Appeals for the Second CircuitJudge: Circuit Judge Denny ChinAttorneys:For plaintiff: For Plaintiffs-Appellants Marc S. Kirschner and Wilmington Savings Fund Society, FSB, in all appeals except Docket Numbers 20-3334 and 20-3335: Robert J. Lack, Stan Chiueh, on the brief, Edward A. Friedman, Friedman Kaplan Seiler & Adelman LLP, New York, New York.
For Plaintiffs-Appellants Marc S. Kirschner and Wilmington Savings Fund Society, FSB, in Docket Numbers 20-3257, 20-3290, 20-3334, 20-3335, 20-3964, and 20-3980: Allan B. Diamond and Ryan M. Lapine, Diamond McCarthy LLP, Dallas, Texas and Los Angeles, California.For defendant: For Defendants-Appellees Public Shareholders (Robeco Capital Growth Funds, et al.): Adam M. Harris and Andrew G. Devore, on the brief, Gregg L. Weiner, Ropes & Gray LLP, New York, New York and Boston, Massachusetts.
For Defendants-Appellees Individual Shareholders Mary E. Belle, Kathleen Nedorostek Kaswell, and Joseph Stafiniak: Danielle C. Lesser, on the brief, Y. David Scharf, Morrison Cohen LLP, New York, New York.
For Defendant-Appellee Individual Shareholder Wayne Kulkin: Howard Seife, Norton Rose Fulbright US LLP, New York, New York.
For Defendants-Appellees Individual Shareholders Katherine Butler, Linda Kothe, Richard Hein, Richard H. Hein Rev. Trust U/A 06/12/95, Mark DeZao, Janice Brown, Eric Dauwalter, Rosa Genovesi, Charles Pickett, Susan McCoy, Stacey Harmon, Kathleen O'Brien, James Capiola, Laurie Gentile, and Robyn Mills: Stuart Kagen and Christopher Greene, Kagen, Caspersen & Bogart, PLLC.
For Defendants-Appellees Individual Shareholders Heather Harlan and George Sharp: Kevin J. O'Connor and Shannon D. Azzaro, Peckar & Abramson, P.C., New York, New York.Case number: 20-3257-cv (L)
A number of recent cases involving blockchain platforms illustrate the difficulties that sometimes emerge in understanding what roles software coders do and don't play when it comes to such systems, and thus whether they may potentially be faced with liability.
17 minute read
"The documents Hemotek relies upon do not demonstrate active attempts to commercialize any particular invention that would satisfy this definition.," the AAA panel said about Hemotek's breach of contract claim.
5 minute read